Related Experiment Videos
Rationale for fixed-dose combination therapy to reach lower blood pressure goals
1Primary Care Service Line, Ralph H. Johnson VA Medical Center, and Medical University of South Carolina, Charleston, South Carolina 29403, USA. jan.basile@va.gov
Insights
Current hypertension guidelines may be too high for high-risk patients. Lower blood pressure targets, especially with combination therapy, may reduce cardiovascular and renal complications. Further research is ongoing.
Area of Science:
- Cardiology
- Nephrology
- Hypertension Management
Background:
- Current hypertension guidelines recommend target blood pressures of <140/90 mm Hg or <130/80 mm Hg for individuals with diabetes, chronic kidney disease, or coronary artery disease.
- These recommendations were based on available clinical data at the time of formulation.
Purpose of the Study:
- To evaluate emerging evidence suggesting that cardiovascular and renal complication risks associated with hypertension may begin at lower blood pressure thresholds (e.g., 115/75 mm Hg).
- To explore the potential benefits of achieving lower blood pressure targets than currently recommended for high-risk populations.
Main Methods:
- Review of accumulating clinical data and evidence regarding hypertension thresholds and complication risks.
- Consideration of combination therapy with multiple agents for effective blood pressure management.
- Acknowledgement of ongoing clinical trials investigating lower blood pressure targets.
Main Results:
- Emerging evidence suggests increased cardiovascular and renal risk may start at 115/75 mm Hg.
- Lowering blood pressure targets beyond current recommendations may offer significant benefits for high-risk patients.
Conclusions:
- Current blood pressure targets may not be sufficiently low for all high-risk individuals.
- Combination therapy is crucial for achieving stringent blood pressure goals in these patients.
- Further research is essential to confirm the risks and benefits of more aggressive blood pressure lowering.
Abstract:
Expert committees in the United States and Europe formulated their currently recommended target blood pressures of <140/90 mm Hg or <130/80 mm Hg in persons with diabetes, chronic kidney disease, or coronary artery disease based on the totality of clinical data available at the time. However, accumulating evidence indicates that increased risk for cardiovascular and renal complications of hypertension may begin at a threshold of 115/75 mm Hg, suggesting that benefit from treatment may occur when blood pressure targets are lower than those currently recommended. Combination therapy with two or more agents having complementary mechanisms of action is the most effective method for achieving strict blood pressure goals in high-risk patients. Several clinical trials are under way to further determine the risks and benefits of lowering blood pressure beyond the currently recommended threshold.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Dosage Regimens: Designs and Approaches
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses